Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Innovative Trials celebrates success for its groundbreaking Retention Patch Program

    November 22, 2024 | PMEA, Patient Retention, clinical trials, patient recruitment 

    Innovative Trials attended the PME Award Gala Dinner last night (21st November 2024)

    - PMLiVE

    While Innovative Trials didn’t take home the award this time, being a finalist for the PME Awards in the Excellence in Collaboration and Partnerships category is still a tremendous honor. This recognition celebrates the innovative Retention Patch Program and the partnership with Oliver Patch Project— which aims to retain children in clinical trials through the ‘Power of Patches’!

    Full press release: https://bit.ly/3V63LGx

    This content was provided by Innovative Trials

    Company Details

    - PMLiVE

    Innovative Trials

    Email
    Website

     Latest Content from  Innovative Trials 

    [Free Case Study Booklet] Accelerating Patient Recruitment in a global rare disease trial

    See how Innovative Trials supported a Top 5 pharma to complete enrollment in a Phase 2 Lupus study

    Pride Month 2023 – Innovative Trials

    Innnovative Trials' Equality & Diversity committee celebrates Pride Month

    [Free Whitepaper] 5 Principles for Greater Diversity in Patient Recruitment

    Discover how community engagement could enhance diversity in clinical trials patient recruitment

    Innovative Trials attended the Inspire Hertfordshire Award gala dinner

    Innovative Trials, a global clinical trial patient recruitment and retention company based in Hertfordshire, has been recognised for its contribution to the county’s economy and business reputation.

    Navigating patients step by step on their clinical trial journey

    For clinical trial participants, navigating their way through a study can sometimes seem daunting and complicated. Without the right support, around 30% are likely to drop out [1], resulting in...

    Innovative Trials responds to national recommendations to tackle UK clinical trial decline

    Kate Shaw, Founder & CEO, comments on the Lord report of the Lord O’Shaughnessy review into commercial clinical trials in the UK.

    Innovative Trials nominates Eloise Moffett as New VP of Commercial

    Eloise Moffett joins Innovative Trials as New Vice President of Commercial to drive business growth globally

    Kate Shaw comments the appointment of an independent review on clinical trials in the UK.

    The news comes after a report by the Association of the British Pharmaceutical Industry (ABPI) highlighted a 44% decline in industry clinical trials in the UK over the last five...

    Patient Recruitment: Think Global, Act Local

    Global clinical trials are a vital component of pharma R&D. Utilizing sites in multiple countries not only provides increased access to eligible and diverse patients - and therefore more robust...

    Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients

    Kate Shaw, Innovative Trials' Founder & CEM, reflects on the exciting news for patients affected by cancer in the UK.